Literature DB >> 24793763

Mechanism and factors that control HIV-1 transcription and latency activation.

Rong-diao Liu1, Jun Wu, Rui Shao, Yu-hua Xue.   

Abstract

After reverse transcription, the HIV-1 proviral DNA is integrated into the host genome and thus subjected to transcription by the host RNA polymerase II (Pol II). With the identification and characterization of human P-TEFb in the late 1990 s as a specific host cofactor required for HIV-1 transcription, it is now believed that the elongation stage of Pol II transcription plays a particularly important role in regulating HIV-1 gene expression. HIV-1 uses a sophisticated scheme to recruit human P-TEFb and other cofactors to the viral long terminal repeat (LTR) to produce full-length HIV-1 transcripts. In this process, P-TEFb is regulated by the reversible association with various transcription factors/cofactors to form several multi-subunit complexes (e.g., 7SK snRNP, super elongation complexes (SECs), and the Brd4-P-TEFb complex) that collectively constitute a P-TEFb network for controlling cellular and HIV-1 transcription. Recent progresses in HIV-1 transcription were reviewed in the paper, with the emphasis on the mechanism and factors that control HIV-1 transcription and latency activation.

Entities:  

Keywords:  HIV-1; P-TEFb; RNA polymerase II; Tat; Transcriptional elongation

Mesh:

Substances:

Year:  2014        PMID: 24793763      PMCID: PMC4076602          DOI: 10.1631/jzus.B1400059

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  85 in total

1.  Structural analyses of the 7SK ribonucleoprotein (RNP), the most abundant human small RNP of unknown function.

Authors:  D A Wassarman; J A Steitz
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

2.  Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase.

Authors:  N F Marshall; J Peng; Z Xie; D H Price
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

Review 3.  Taking a new TAK on tat transactivation.

Authors:  K A Jones
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

4.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.

Authors:  Y Zhu; T Pe'ery; J Peng; Y Ramanathan; N Marshall; T Marshall; B Amendt; M B Mathews; D H Price
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

5.  The bromodomain revisited.

Authors:  F Jeanmougin; J M Wurtz; B Le Douarin; P Chambon; R Losson
Journal:  Trends Biochem Sci       Date:  1997-05       Impact factor: 13.807

6.  ELL2, a new member of an ELL family of RNA polymerase II elongation factors.

Authors:  A Shilatifard; D R Duan; D Haque; C Florence; W H Schubach; J W Conaway; R C Conaway
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

7.  The accuracy of reverse transcriptase from HIV-1.

Authors:  J D Roberts; K Bebenek; T A Kunkel
Journal:  Science       Date:  1988-11-25       Impact factor: 47.728

8.  An RNA polymerase II elongation factor encoded by the human ELL gene.

Authors:  A Shilatifard; W S Lane; K W Jackson; R C Conaway; J W Conaway
Journal:  Science       Date:  1996-03-29       Impact factor: 47.728

Review 9.  Control of RNA initiation and elongation at the HIV-1 promoter.

Authors:  K A Jones; B M Peterlin
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

10.  Purification of P-TEFb, a transcription factor required for the transition into productive elongation.

Authors:  N F Marshall; D H Price
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

View more
  5 in total

1.  Transcription: the epicenter of gene expression.

Authors:  Jiannan Guo
Journal:  J Zhejiang Univ Sci B       Date:  2014-05       Impact factor: 3.066

Review 2.  Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.

Authors:  Guillaume Mousseau; Susana T Valente
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

3.  The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC.

Authors:  Hassen S Wollebo; Anna Bellizzi; Dominique H Cossari; Julian Salkind; Mahmut Safak; Martyn K White
Journal:  J Neurovirol       Date:  2016-03-23       Impact factor: 2.643

Review 4.  From Entry to Egress: Strategic Exploitation of the Cellular Processes by HIV-1.

Authors:  Pavitra Ramdas; Amit Kumar Sahu; Tarun Mishra; Vipin Bhardwaj; Ajit Chande
Journal:  Front Microbiol       Date:  2020-12-04       Impact factor: 5.640

5.  Altered HIV-1 mRNA Splicing Due to Drug-Resistance-Associated Mutations in Exon 2/2b.

Authors:  Lisa Müller; Wiebke Moskorz; Anna-Lena Brillen; Frank Hillebrand; Philipp Niklas Ostermann; Niklas Kiel; Lara Walotka; Johannes Ptok; Jörg Timm; Nadine Lübke; Heiner Schaal
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.